Chartwell Pharmaceuticals Revenue and Competitors

Claim your profile



Total Funding



Estimated Revenue & Valuation

  • Chartwell Pharmaceuticals's estimated annual revenue is currently $16.1M per year.(i)
  • Chartwell Pharmaceuticals's estimated revenue per employee is $201,000

Employee Data

  • Chartwell Pharmaceuticals has 80 Employees.(i)
  • Chartwell Pharmaceuticals grew their employee count by 10% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation

CHARTING A COURSE TO WELLNESS Chartwell Pharmaceuticals is a US-based development, manufacturing and commercial organization located in Congers, New York. Our facility produces prescription pharmaceutical products with a commitment to superior quality, compliance, and customer service. Chartwell Pharmaceuticals has a long history as a preferred manufacturing partner for prescription solid dosage products in tablet, capsule, and powders forms. Our rooms are large, our ceilings are high, and facilities are pristine. Our exceptional hands-on leadership team and technical staff bring decades of pharmaceutical industry experience in manufacturing and analytical services for development, scale-up, transferring, changing, launching, and supplying products. Under our own Chartwell labels, our mission is to provide a consistent, timely and quality product supply to our pharmacy customers and their patients. Our current portfolio stands at over 70 Orange Book listed ANDAs and NDAs, with an aggressive asset development and acquisition program in place. Supported by Chartwell Actives, our API Development team, and Chartwell Labs, our Formulations and Analytical team, we are quickly continuing to broaden our line through commercial Chartwell-labeled branding. Chartwell Pharmaceuticals is proud to be manufacturing "Made in the USA" products.

keywords:Biotechnology,Hardware,Hardware Peripherals,Healthcare,Pharmaceuticals


Total Funding


Number of Employees


Revenue (est)


Employee Growth %





Chartwell Pharmaceuticals News

2022-03-30 - Lyme Disease Treatment Market To Reach Valuation Of US ...

... Chartwell Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Orion Corporation, and Amneal Pharmaceuticals LLC.

2019-09-06 - Foresite Capital Management Ii Acquires 3847 Shares of ...

Aerie Pharmaceuticals Inc (NASDAQ:AERI) major shareholder Foresite ... Chartwell Investment Partners LLC now owns 70,484 shares of the ...

2019-09-04 - Aerie Pharmaceuticals Inc (NASDAQ:AERI) Major ...

Aerie Pharmaceuticals Inc (NASDAQ:AERI) Major Shareholder Foresite Capital ... Chartwell Investment Partners LLC raised its stake in Aerie ...

2019-02-21 - Rockland pill producer Chartwell Pharma sues Florida ...

Chartwell Therapeutics Licensing LLC in Congers is demanding payment for pills, $4.1 million worth, that it claims a distributor has refused to ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding